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Abstract: The objective of this review is to explore the relationship between alcohol and 
the  metabolism  of  the  essential  micronutrient,  vitamin  A;  as  well  as  the  impact  this 
interaction has on alcohol-induced disease in adults. Depleted hepatic vitamin A content 
has been reported in human alcoholics, an observation that has been confirmed in animal 
models of chronic alcohol consumption. Indeed, alcohol consumption has been associated 
with declines in hepatic levels of retinol (vitamin A), as well as retinyl ester and retinoic 
acid; collectively referred to as retinoids. Through the use of animal models, the complex 
interplay between alcohol metabolism and vitamin A homeostasis has been studied; the 
reviewed  research  supports  the  notion  that  chronic  alcohol  consumption  precipitates  a 
decline in hepatic retinoid levels through increased breakdown, as well as increased export 
to extra-hepatic tissues. While the precise biochemical mechanisms governing alcohol’s 
effect remain to be elucidated, its profound effect on hepatic retinoid status is irrefutable. 
In addition to a review of the literature related to studies on tissue retinoid levels and the 
metabolic interactions between alcohol and retinoids, the significance of altered hepatic 
retinoid metabolism in the context of alcoholic liver disease is also considered. 
Keywords: ethanol; retinol; retinyl ester; retinoic acid; hepatocyte; hepatic stellate cell; 
cytochrome P450; alcohol dehydrogenase; aldehyde dehydrogenase 
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1. Introduction 
The primary pathway for ethanol metabolism in the human body is its oxidative metabolism from 
ethanol  to  acetaldehyde,  and  then  to  acetic  acid.  Furthermore,  ethanol  can  also  undergo  so  called  
non-oxidative metabolism, which includes the esterification of ethanol into fatty acid ethyl esters, as 
well as its conversion into phosphatidylethanol [1,2]. Similarly, the metabolism of dietary vitamin A 
follows a parallel pathway, including the oxidative metabolism of retinol to retinaldehyde, then to the 
canonically active form of vitamin A, retinoic acid (collectively referred to as retinoids; Figure 1) [3]. 
Given  these  biochemical  parallels,  it  is  perhaps  not  surprising  that  ethanol  has  been  shown  to 
negatively affect retinoid homeostasis following both acute and chronic ethanol exposure. Indeed, as 
discussed below, enzymes which are involved in ethanol metabolism are also thought to affect retinoid 
homeostasis, such as alcohol dehydrogenase and cytochrome P450 2E1 (CYP2E1). The scope of this 
review includes alcohol’s effect on retinoid metabolism and homeostasis in adult tissues, particularly 
the liver; however, it should be noted that ethanol has also been proposed to disrupt retinoid signaling 
during development which has been associated with fetal alcohol syndrome. This subject will not be 
covered in the current review and the reader is directed toward the existing review literature on fetal 
alcohol syndrome and retinoids [4,5].  
Figure 1. Biochemical parallels in the metabolism of ethanol and retinol. The conversion 
of ethanol to acetaldehyde is mediated by different processes within the cell; this reaction 
can  be  catalyzed  by  alcohol  dehydrogenase,  CYP2E1,  and  to  a  lesser  extent,  catalase.  
The conversion of the primary alcohol, retinol, to retinaldehyde can also be catalyzed by 
alcohol dehydrogenase subtypes, as well as specific retinol dehydrogenases. In both cases, 
the subsequent oxidation of the aldehyde to a carboxylic acid is mediated by aldehyde 
dehydrogenases. Within the liver, the synthesis of retinyl ester is catalyzed by lecithin: 
retinol acyltransferase (LRAT); the molecular identity of enzymes which synthesize fatty 
acid ethyl esters are currently unknown. 
 
2. Vitamin A Deficiency and Alcoholism 
It has long been recognized that alcoholics are generally malnourished and can suffer from vitamin A 
deficiency (VAD) [6,7]. A common consequence of alcoholism is loss of night vision (nyctalopia),  
a condition that is associated with VAD [7–10]. While this manifestation of VAD is relatively mild, 
the  ophthalmic  symptoms  of  continued  VAD  include  xerophthalmia  and  can  ultimately  lead  to 
blindness. Though this is a rare occurrence in alcoholics, there are case reports of xerophthalmia in this 
patient  group  [11].  In  addition  to  clinical  manifestations  of  VAD,  several  studies  have  reported Nutrients 2012, 4  358 
 
 
biochemical  measures  of  vitamin  A  status  in  alcoholics.  Decreased  plasma  retinol  levels  and  
plasma  retinol  binding  protein  (RBP)  concentrations  have  been  reported  in  alcoholics  by  several 
groups [10,12,13]; however, it was the landmark 1982 study by Leo and Lieber that established the 
profound effect that alcohol can have on hepatic vitamin A status [14]. In their manuscript, these 
authors reported the hepatic vitamin A levels of control subjects and compared them to patients with 
advancing  stages  of  alcoholic  liver  disease  (fatty  liver,  hepatitis,  cirrhosis),  finding  a  significant 
decrease  in  hepatic  retinoid  content  which  correlated  with  disease  severity.  These  authors  also 
confirmed the previously observed decrease in plasma retinol and RBP levels in alcoholics, though 
only  in  those  patients  with  more  advanced  stages  of  disease  (hepatitis  and  cirrhosis).  This  latter 
observation was significant because it emphasized that alcoholics with plasma retinol levels in the 
normal range may still have significant depletion of hepatic retinoid stores. The observed decrease in 
hepatic retinoid content of alcoholics has been independently confirmed; it has also subsequently been 
shown  that  retinoid  levels  are  decreased  in  both  hepatocytes  and  hepatic  stellate  cells  (HSC). 
Furthermore, separate quantification of hepatic retinol and retinyl ester concentrations found that both 
retinoid species were decreased in the livers of alcoholics [15–17]. 
While it is apparent that alcoholics often have a generalized nutrient deficiency, research in alcohol-fed 
baboons and rodents established that alcohol was able to deplete hepatic retinoid stores independent of 
dietary vitamin A intake and absorption [6,7,18]. Thus, it is clear that chronic consumption of alcohol 
in humans causes a progressive depletion of hepatic retinoid stores, and that alcoholics are prone to 
developing clinical symptoms of VAD. What is less clear, however, is the effect that altered retinoid 
homeostasis has on progression of alcohol-induced disease, a topic which is discussed below in Section 5. 
3. Effect of Alcohol Consumption on Tissue Retinoid Levels 
Following the observed effects of alcohol on retinoid homeostasis in humans, numerous studies in 
animal  models  have  been  undertaken  to  identify  the  mechanisms  through  which  alcohol  affects 
retinoid  metabolism,  as  well  as  the  impact  this  may  have  on  the  development  of  alcohol-induced 
disease. As mentioned above, depleted hepatic retinoid content observed in humans has also been 
observed in baboons and rodents chronically fed alcohol. Sato and Lieber fed a cohort of baboons 
alcohol  and  compared  them  to  control  animals,  observing  decreased  hepatic  retinoid  content  after 
4 months of alcohol consumption, which was further depleted in a time-dependent manner with up to 
2 years  of  alcohol  consumption  [18].  While  this  research  carried  out  in  primates  is  perhaps  most 
applicable to human health and disease, the majority of research studying the interactions between 
alcohol  and  vitamin  A  has  been  performed  in  rodents  (summarized  in  Table  1).  Nevertheless,  a 
consistent pattern emerges: chronic alcohol consumption is associated with a significant decrease in 
hepatic retinol and retinyl ester content. Interestingly, many animal studies have failed to recapitulate 
the decreased plasma retinol levels observed in human alcoholics, this may be because of the adequate 
nutrition provided in the experimental setting or the absence of severe hepatic disease induced by  
these models.  Nutrients 2012, 4  359 
 
 
Table 1. Summary of rodent studies exploring the effect of chronic alcohol consumption 
on hepatic retinoid status. 
Lead author (year of publication)  
[reference number] 
Species (strain)  Hepatic retinoid status 
Sato (1981) [18]  Rat (Sprague-Dawley)  Decreased 
Leo (1986) [19]  Rat (Sprague-Dawley)  Decreased 
Mobarhan (1986) [20]  Rat (Sprague-Dawley)  Decreased 
Mobarhan (1991) [21]  Rat (Fischer 344)  Decreased 
# 
Chapman (1992) [22]  Rat (Sprague-Dawley)  Decreased 
Wang (1998) [23]  Rat (Sprague-Dawley)  Decreased 
Chung (2001) [24]  Rat (Sprague-Dawley)  Decreased 
Liu (2002) [25]  Rat (Sprague-Dawley)  Decreased 
Chung (2009) [26]  Rat (Sprague-Dawley)  Decreased 
Kane (2010) [27]  Mouse (C57BL/6)  Decreased 
Luvizotto (2010) [28]  Rat (Fisher 344)  Decreased 
# Mobarhan et al. (1991) studied old and young rats, and only observed a decreased in hepatic retinoid 
content in younger animals [21]. 
In  addition  to  measures  of  total  hepatic  retinoid  content,  the  effect  of  alcohol  consumption  on 
individual  cell  types  within  the  liver  has  been  studied.  Perhaps  the  most  significant  cell  type  to 
consider here is the HSC. This cell type accounts for approximately 5 to 8% of liver cells, yet it stores 
greater than 90% of hepatic retinoid content (in the form of retinyl ester) within specialized lipid 
droplets [29]. Rasmussen et al. (1985) measured the retinoid content of parenchymal (hepatocyte) 
preparations (approximately 95% pure) and nonparenchymal cell preparations, reporting a significantly 
decreased total retinoid content in both cell populations isolated from alcohol-fed rats; however, the 
largest  quantitative  drop  was  observed  in  the  nonparenchymal  cell  population  which  contained 
approximately 10% HSCs [30]. Using a more sophisticated approach to isolate the individual cell types 
of  the  rat  liver,  Cottalasso  et  al.  (2003)  also  reported  decreased  retinol  content  associated  with  
alcohol-feeding in hepatocytes, HSCs, Kupffer cells and endothelial cells [31]. In agreement with these 
animal studies, it has been shown that depletion of hepatic  retinoid stores in alcoholics occurs in 
hepatocytes and HSCs [17]. Taken together, these studies indicate that chronic alcohol consumption is 
associated  with  decreased  retinoid  content  in  all  of  the  main  cell  types  of  the  liver,  though 
quantitatively this decrease is largest in HSCs.  
Despite the evidence of depleted hepatic retinoid content in chronic alcoholics, it remains to be 
established  whether  dietary  vitamin  A  supplementation  would  have  a  beneficial  effect  on  liver 
pathology. Conflicting results have been published on the effect of vitamin A supplementation to rats 
chronically consuming alcohol, with one group reporting an enhancement of liver injury (increased 
lipid accumulation and increased indicators of steatohepatitis) [32,33], and a second group reporting no 
effect of vitamin A supplementation [34,35]. These opposite results are difficult to reconcile, though 
differences in study design make direct comparisons problematic. For example, while both studies 
used the same high amount of vitamin A and dietary alcohol content, the studies were conducted in 
different strains of rat and over different time periods. This issue is further complicated by reports 
demonstrating  that  supplementation  with  retinoic  acid  in  rats  chronically  consuming  alcohol  is Nutrients 2012, 4  360 
 
 
associated  with  decreased  liver  injury  [24,36,37],  whereas  supplementation  with  β-carotene 
exacerbates liver injury [38,39]. Thus, there is conflicting data on the effect of exogenous retinoid 
supplementation  in  rats  chronically  consuming  alcohol.  The  effect  of  dietary  retinoid  intake  in 
alcoholic liver disease, be it positive or negative, remains to be resolved.  
In addition to the profound effect that chronic alcohol consumption has on hepatic retinoid levels, it 
also  became  apparent  that  alcohol  impacted  retinoid  levels  in  extra-hepatic  tissues.  Interestingly, 
whereas alcohol consumption was shown to decrease hepatic retinoid levels, these levels are actually 
increased in extra-hepatic tissues, leading to the concept that alcohol stimulates the mobilization of 
hepatic  retinoid  stores  to  extra-hepatic  tissues.  To  summarize  the  multiple  studies  which  have 
investigated this phenomenon, there is evidence to suggest the chronic alcohol consumption increases 
tissues  retinoid  levels  in  specific  brain  regions,  the  colon,  esophagus,  kidney,  lung,  testes  and  
trachea [18–22,27,40]. It is important to note that although all of the studies mentioned above were 
focused on the effects of chronic alcohol consumption, it is also known that acute ethanol exposure can 
affect  tissue  retinoid  levels.  Similar  to  the  effects  of  chronic  alcohol  consumption,  acute  alcohol 
exposure  has  been  shown  to  precipitate  a  decline  in  hepatic  retinoid  content,  with  a  concomitant 
increase in extra-hepatic tissue retinoid levels (specifically serum, adipose, and kidney) [27,41,42].  
As mentioned above, retinoic acid is the active metabolite of dietary vitamin A, which functions as 
a ligand for nuclear transcription factors to control the expression of more than 500 genes [43]. While 
the studies discussed thus far indicate that chronic alcohol consumption depletes the liver of its retinyl 
ester and retinol content, more recent work has also evaluated alcohol’s effect on retinoic acid levels, 
as reviewed by Napoli [44]. In brief, several studies have described decreased hepatic retinoic acid 
levels in alcohol-fed rats and mice, as measured by high-pressure liquid chromatography, as well as 
decreased  plasma  levels  of  retinoic  acid  [23–26,28,45,46].  Furthermore,  data  from  PAV-1  cells  
(an  immortalized  HSC  line,)  supports  the  notion  that  alcohol  inhibits  retinoic  acid  formation,  as 
reflected  by  alcohol’s  inhibitory  effect  on  the  induction  of  a  retinoic  acid-inducible  promoter, 
stimulated  upon  retinol  administration  [47].  In  contrast,  it  was  recently  reported  that  retinoic  
acid  levels  were  unchanged  in  the  livers  of  mice  chronically  fed  alcohol  and  that  extra-hepatic  
levels  (including  plasma)  were  increased,  as  measured  by  liquid  chromatography-tandem  mass 
spectrometry [27]. Some reviewers have favored this most recent dataset given the more sensitive 
methodology  used  [48];  however,  it  is  our  opinion  that  to  disregard  the  previous  studies  may  be 
premature. Given the importance of retinoic acid in controlling gene  expression, and the fact that 
steady-state levels of retinoic acid may not directly reflect responses in gene expression, it will be 
important to clarify the effect alcohol has on hepatic and extra-hepatic retinoic acid levels in order to 
better  understand  the  importance  of  alcohol-induced  changes  in  retinoic  acid  as  a  mechanism  of 
alcohol toxicity, not only in the liver, but also in extra-hepatic tissues. 
A further aspect of alcohol’s interaction with vitamin A homeostasis that has not been discussed 
thus far, is the metabolism of the dietary provitamin A carotenoid, β-carotene; metabolism of which 
can  yield  bioavailable  vitamin  A  to  meet  the  body’s  needs.  An  in  depth  discussion  of  alcohol’s 
interaction with metabolism of this nutrient can be found in the 1999 article by Leo and Lieber [49].  
In brief, while studies in humans have reported a decrease in plasma β-carotene, detailed analysis  
and  control  for  nutrient  intake  suggest  there  may  actually  be  a  relative  increase  in  its  circulating  
levels [49–54]; furthermore experimental studies in alcohol-fed baboons have reported a significant 
increase in circulating and hepatic levels of β-carotene [38]. While it was speculated that the increased Nutrients 2012, 4  361 
 
 
levels of β-carotene observed with chronic alcohol consumption might be associated with inhibition of 
its cleavage into retinal [49], more recent studies have shown that alcohol increases hepatic expression 
of carotenoid cleavage enzymes (CMO1 and CMO2) which catalyze this reaction (though β-carotene 
levels  were  not  reported)  [28].  As  such,  increased  carotenoid  cleavage  enzyme  expression  seems  
to  argue  against  a  mechanism  whereby  alcohol  inhibits  cleavage  of  β-carotene,  leading  to  its 
accumulation in the liver. Thus it appears that further studies will be required to better understand the 
unique  interaction  that  alcohol  has  with  β-carotene  metabolism,  as  well  as  its  impact  on  hepatic 
retinoid metabolism as a whole. An important caveat should also be added here, specifically, it should 
be noted that experimental rodents typically have low amounts of β-carotene in their diets, and they are 
also  inefficient  at  absorbing  it,  thus  extra  care  should  be  taken  when  interpreting  and  conducting 
studies on alcohol-fed rodents concerning β-carotene metabolism. 
Figure 2. A simplified overview of retinoid metabolism in a hypothetical cell. This scheme 
reflects  retinoid  metabolism  in  a  hypothetical  cell.  The  reader  should  note  that  these 
processes do not typically occur within all cells in vivo, but have been grouped here for 
simplicity. Similarly, multiple isoforms exist for many of the binding proteins and enzymes 
presented below; for a complete review of retinoid metabolism, please refer to the recent 
review by D’Ambrosio et al. [55]. In the cytoplasm, retinol is bound to a cellular retinol-
binding protein (CRBP), from this point there are three possible pathways for retinol to 
take. First, retinol can be transferred to retinol-binding protein (RBP), which itself is bound 
to transthyretin (TTR), and secreted into the circulation. Second, it can be esterified into 
retinyl  ester by  lecithin:retinol acyltransferase  (LRAT), and stored in  cytoplasmic lipid 
droplets. Third, it can be metabolized into retinaldehyde and subsequently converted into 
retinoic  acid.  Retinoic  acid  may  be  bound  by  a  cellular  retinoic  acid  binding  protein 
(CRABP), which can direct it toward the nucleus where it can signal through the nuclear 
transcription factors retinoic acid receptor (RAR) and retinoid X receptor (RXR), or it can 
be  directed  toward  catabolism  into  polar  metabolites  by  various  members  of  the 
cytochrome P450 family (CYP). Catalytic enzymes are shown in red text; binding proteins 
are  in  blue  text.  ADH:  alcohol  dehydrogenase;  RALDH:  retinaldehyde  dehydrogenase; 
RDH: retinol dehydrogenase; REH: retinyl ester hydrolase. 
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4. Interactions between Alcohol and Hepatic Retinoid Metabolism 
The studies discussed above provide compelling evidence that chronic alcohol consumption leads to 
a depletion of hepatic retinoid stores; however, the mechanism to explain this phenomenon remains 
elusive.  Early  nutritional  studies  established  that  the  drop  in  hepatic  retinoid  content  occurred 
independently  of  dietary  vitamin  A  intake,  and  that  malabsorption  from  the  intestine  was  not 
responsible.  Two  hypotheses  to  explain  alcohol’s  effect  subsequently  emerged;  (1)  that  alcohol 
stimulates  mobilization  of  hepatic  retinoid  stores  to  extra-hepatic  tissues;  and  (2)  that  alcohol 
stimulates retinoid catabolism [18]. Other posited explanations include reduced uptake of vitamin A 
into the liver from chylomicron remnants, reduced transfer of retinol from hepatocytes to HSCs, and 
reduced storage capacity of HSCs [30]. The next section of this review contains a detailed dissection of 
alcohol’s  interaction  with  the  retinoid  metabolic  pathway,  providing  a  biochemical  basis  for 
understanding alcohol’s effect on tissue retinoid levels; a general overview of retinoid metabolism is 
provided in Figure 2 for the reader’s orientation. 
4.1. Synthesis and Hydrolysis of Hepatic Retinyl Ester Stores 
Vitamin A is stored in HSCs in the form of retinyl ester, which is packaged into cytoplasmic lipid 
droplets. In times of dietary vitamin A insufficiency, stored retinyl ester can be hydrolyzed into retinol, 
which is transferred to hepatocytes, packaged with RBP, and secreted into the circulation in order to 
meet the body’s need for vitamin A. Hydrolysis of retinyl ester is catalyzed by a retinyl ester hydrolase 
(REH); however, the exact molecular identity of this enzyme activity in HSCs remains unclear [29]. 
The effect of ethanol on REH activity has been studied in vitro using liver homogenates, revealing that 
alcohol exerts a dose dependent increase in REH activity but acetaldehyde can inhibit REH [56]. These 
opposing results are difficult to interpret in the context of alcohol consuming mice, which would be 
expected to have elevated concentrations of alcohol and its metabolite, acetaldehyde. Perhaps data that 
is  more  representative  of  alcohol’s  effect  on  REH  activity  in  vivo  comes  from  studies  in  rats 
chronically  fed  alcohol;  in  this  case,  hepatic  microsomes  isolated  from  alcohol-fed  animals  had 
significantly decreased rates of REH activity, as compared to controls [21]. This data suggests that 
mobilization of hepatic retinyl ester is unlikely to be mediated by a direct effect of alcohol on REH 
activity; however, an indirect mechanism has been proposed. In this case, it has been hypothesized that 
alcohol  increases  hepatic  levels  of  apo-CRBPI  (cellular  retinol  binding  protein,  type  1),  a  high 
concentration of which relative to holo-CRBPI, is proposed to stimulate hydrolysis of retinyl ester and 
inhibit its esterification [57,58]. Though definitive data is lacking, this hypothesis is supported by 
evidence indicating that hepatic CRBPI mRNA expression is upregulated by ethanol exposure, and 
that  CRBPI-null  mutant  mice  are  resistant  to  alcohol-induced  depletion  of  hepatic  retinoid  
stores [25,27]. As indicated above, it is also possible that alcohol has an effect on the synthesis of 
retinyl  ester  within  HSCs,  though  it  has  been  shown  that  alcohol  has  no  effect  on  LRAT 
(lecithin:retinol acyltransferase) mRNA expression and that synthesis of retinyl palmitate from retinol 
is  unaffected  by  alcohol  feeding  [25].  Take  together,  it  would  appear  that  there  is  no  definitive 
evidence to conclude that alcohol has a direct effect on the rates of hydrolysis or synthesis of retinyl Nutrients 2012, 4  363 
 
 
ester in the liver, and that depletion of hepatic retinyl esters stores is secondary to alcohol’s effect upon 
another step in the retinoid metabolic pathway. 
4.2. Synthesis of Retinoic Acid 
As shown in Figure 2, retinoic acid is synthesized from retinol in a two-step process in which 
retinol is oxidized to retinaldehyde followed by the subsequent oxidation of retinaldehyde to retinoic 
acid. The synthesis of retinaldehyde from retinol can be catalyzed by several enzymes, which can be 
broadly  split  into  two  categories:  (1)  medium-chain  alcohol  dehydrogenases  with  specific  activity  
for retinol (e.g., ADH1, ADH3, ADH4); and (2) retinol dehydrogenases which are members of the 
short-chain dehydrogenase/reductase family (e.g., RDH1 and RDH10) [59]. It is currently thought that 
the retinol dehydrogenase enzymes function in hepatic retinol metabolism at physiological levels, and 
that alcohol dehydrogenases produce retinoic acid only when excess retinol levels are present [60].  
In the early literature, the role of alcohol inhibiting the conversion of retinol to retinaldehyde by ADH1 
was  focused  on  because  of  ADH1’s  high  expression  level  in  the  liver  and  its  important  role  in  
ethanol metabolism. Interestingly, in vitro data indicated that ethanol is a potent inhibitor of alcohol 
dehydrogenase  catalyzed  oxidation  of  free  retinol  to  retinaldehyde,  particularly  ADH1  [61,62]; 
however this effect is apparently attenuated when retinol is bound to CRBP [63,64]. Thus, if we accept 
that the majority of cellular retinol is bound by CRBP, it would appear that retinol metabolism by 
ADH1 is not an important pathway in the alcoholic liver. This conclusion is supported by recent data 
which shows that acute inhibition of ADH with 4-methylpyrazole did not change alcohol’s effect on 
cellular retinoic acid levels [27]. Interestingly though, the effect of alcohol on cellular retinoic acid 
concentration was blocked by inhibition of retinol dehydrogenase, suggesting that alcohol may affect 
this pathway [27]. 
The second step in the synthesis of retinoic acid from retinol is the oxidation of retinaldehyde to 
retinoic acid (Figure 2); this reaction is catalyzed by members of the retinaldehyde dehydrogenase 
family (RALDH1 [ALDH1a1], RALDH2 [ALDH1a2] and RALDH3 [ALDH1a3]) [59]. Though this 
step has been less studied with regard to alcohol, it has been reported that hepatic microsomes isolated 
from alcohol-fed rats have increased retinaldehyde dehydrogenase activity, which was associated with 
the depletion of hepatic retinoid observed in these animals [65]. 
In summary, when considering the synthesis of retinoic acid one must keep in mind that it is a  
two-step  process,  in  which  the  first  step  uses  retinol  as  a  substrate  and  is  potentially  affected  by 
alcohol, whereas the second step utilizes retinaldehyde as a substrate and is potentially affected by 
acetaldehyde. However, there is currently no definitive experimental evidence to support the concept 
that alcohol may inhibit retinoic acid synthesis by inhibiting its oxidation from retinol to retinaldehyde. 
Indeed, while the idea exists that oxidation of retinol is the rate-limiting step in retinoic acid synthesis, 
and is thus essential in controlling cellular levels of retinoic acid, a different regulatory mechanism has 
been proposed. In this model, retinoic acid levels are controlled by two factors: substrate availability 
and  catabolism.  Specifically,  Ross  and  colleagues  have  proposed  that  levels  of  the  retinoic  acid 
precursor molecule, retinol, are tightly controlled by its sequestration into retinyl ester, catalyzed by 
LRAT, and secondly, retinoic acid itself is regulated by its catabolism, mediated by cytochrome P450 Nutrients 2012, 4  364 
 
 
enzymes  [66].  The  effect  of  chronic  alcohol  consumption  on  the  catabolism  of  retinoic  acid  is 
discussed in the next section. 
4.3. Catabolism of Retinoic Acid 
Under physiological conditions, the catabolism of retinoic acid is catalyzed by cytochrome P450 
enzymes. While the actions of CYP26A1, 26B1 and 26C1 in retinoic acid catabolism have been well 
established,  particularly  during  embryogenesis,  several  other  cytochrome  P450  enzymes  have  also 
been posited to metabolize retinoic acid, including several members of the CYP2C family [67]. In the 
context of chronic alcohol consumption, decreased levels of hepatic retinoic acid have often been 
associated with enhanced breakdown of this transcriptionally active vitamin A metabolite. There are 
three lines of evidence which support this notion, (1) decreased steady state levels of retinoic acid  
in  the  liver  of  alcohol-fed  rodents  (see  above);  (2)  direct  evidence  of  increased  retinoic  acid  
breakdown  [27,45,46];  and  (3)  increased  levels  of  polar  retinoic  acid  metabolites,  such  as  
4-oxo-retinoic acid and 18-hydroxy-retinoic acid, in the liver of alcohol-fed rodents [25,26,45,68]. 
Chronic  alcohol  consumption  is  known  to  induce  the  cytochrome  P450  enzyme  CYP2E1  [69]. 
Enhanced cytochrome P450 activity was associated with decreased hepatic retinoid content since some 
of the first feeding experiments in rodents were performed [18], the hypothesis that retinoic acid is 
metabolized in the alcoholic liver by CYP2E1 has been borne out by studies using a CYP2E1 inhibitor 
(chlormethiazole; CMZ). Treatment with this compound has been shown to normalize hepatic retinoic 
acid  levels  and  prevent  the  appearance  of  retinoic  acid  metabolites  in  a  dose-dependent  
manner [25,26,68]. Interestingly, not only did CMZ treatment prevent alcohol-induced decreases in 
hepatic  retinoic  acid  levels,  but  it  also  normalized  hepatic  retinol  and  retinyl  ester  levels  [25].  
This intriguing  result suggests that by preventing the breakdown of retinoic acid within the liver, 
alcohol-induced  depletion  of  retinol  and  retinoic  acid  can  also  be  avoided,  thus  the  increased 
metabolism of retinoic acid within the alcohol-exposed liver could be the main driving force behind 
the depleted level of hepatic retinoids, such that retinyl ester stores  are channeled through retinol 
oxidation to retinoic acid which is subsequently broken down by CYP2E1.  
Our goal in this section was to summarize the numerous studies which have sought to explain the 
mechanism through which alcohol consumption depletes hepatic retinoid levels. Other authors have 
attempted  to  synthesize  the  pleiotropic  effects  of  alcohol  into  one  scheme,  and  here  we  defer  to  
them [27,70]. Suffice to say, in vitro studies provide compelling evidence that alcohol can disrupt 
several steps in the metabolism of retinol; however, the effect in vivo is less clear. It is likely that 
depletion of hepatic retinoid stores is a dynamic process and that mobilization to extra-hepatic tissues 
and enhanced retinoid catabolism both contribute to this effect. An important issue to be resolved in 
this  regard  is  the  relative  contribution  of  these  mechanisms,  both  in  terms  of  time  and  quantity.  
A further important issue is the effect that alcohol-associated alterations in retinoid homeostasis have 
on alcohol-induced disease development; this is the subject of the next section. 
5. Effect of Altered Retinoid Homeostasis on Alcohol-Induced Disease 
One of the organs most affected by chronic alcohol consumption is the liver; the progression of 
disease  in  chronic  alcoholics  typically  begins  with  fatty  liver,  which  can  then  develop  into Nutrients 2012, 4  365 
 
 
steatohepatitis,  fibrosis,  and  cirrhosis.  The  development  of  fibrosis  in  liver  disease  involves  the 
activation of HSCs, which transition from quiescent vitamin A-storing cells to myofibroblasts [71]. 
Significantly, a prerequisite step in the activation of HSCs is the loss of their retinyl ester stores [29], 
thus at a superficial level we can draw an association between alcohol-induced depletion of hepatic 
retinoid  stores  and  the  progression  of  alcohol-induced  disease;  however,  the  cause  and  effect 
relationship between alcohol-induced depletion of hepatic retinoid and development of disease has not 
been  definitively  ascertained.  Two  leading  hypotheses  have  been  forwarded  which  explore  this 
relationship, one we call here the retinoid insufficiency hypothesis and the second, the toxic burst 
hypothesis [25]. In the retinoid insufficiency hypothesis, it is postulated that alcohol-induced loss of 
hepatic retinoid content results in a state of hepatic retinoid insufficiency, thus disrupting essential 
retinoid-dependent  cellular  functions  and  precipitating  disease.  In  this  context,  hepatic  retinoid  
stores can be viewed as being protective against disease development. In the toxic burst hypothesis, 
alcohol-induced aberrations in hepatic retinoid metabolism results in a toxic burst of transcriptionally 
active  retinoid  metabolites,  presumable  generated  by  CYP2E1,  which  directly  contribute  to  the 
development of alcoholic liver disease [25].  
As  stated  above,  these  hypotheses  have  been  largely  untested,  though  data  from  the  existing 
literature can be found to support each of them. For example, the retinoid insufficiency hypothesis is 
supported  by  several  studies  showing  that  interventions  that  ameliorate  the  development  of  
alcohol-induced disease are associated with the preservation of hepatic retinoid levels [68,72,73]. With 
regard to the toxic burst hypothesis, Dan et al. studied the toxicity of polar retinol metabolites in the 
pathogenesis of alcohol-induced liver disease, finding them to be cytotoxic to HepG2 cells and primary 
rat hepatocytes [74]. It is also known that blocking CYP2E1, which inhibits the formation of retinoic 
acid metabolites, protects against the development of alcoholic liver disease in animal models [75,76], 
though it is important to remember that CYP2E1 has an important role in alcohol metabolism and its 
inhibition may have other effects beyond normalizing retinoid metabolism. While these studies can be 
interpreted to favor a specific hypothesis, the reader is reminded that these associations are largely 
correlative and definitive data is lacking. 
A  further  complication  of  chronic  alcoholism  is  the  development  of  hepatocellular  carcinoma 
(HCC); analysis of retinoid content in HCC tissue and surrounding noncancerous tissue from patients 
with a history of alcoholism revealed a low retinoid content, which was more pronounced in HCC 
tissue, leading the authors to conclude that depleted hepatic retinoid content may be a factor in HCC 
development in alcoholics [17]. It is not only an increased risk of liver cancer that has been associated 
with alcoholism; alcohol consumption is also associated with increased rates of several types of cancer 
in addition to HCC, including cancer of the upper aerodigestive tract, colorectal cancer and female 
breast cancer [77]. Furthermore, some of these cancers have been linked with changes in retinoid 
homeostasis, such as tracheal squamous metaplasia [78–80]. The reader is directed towards the review 
by Wang, which specifically address the associations between alcohol, cancer and vitamin A [70].  
An understudied aspect of alcohol’s effect on retinoid homeostasis, with respect to alcohol-induced 
disease, is its effect on other organ systems. While most studies have focused on the liver, it is known 
that  chronic  alcohol  consumption  affects  retinoid  homeostasis  in  extra-hepatic  tissues,  generally 
leading to an increase in retinoid levels (discussed above). For example, an association has been made 
between  male  sterility  in  alcoholics  and  altered  testicular  retinoid  homeostasis  [81,82].  As  such, Nutrients 2012, 4  366 
 
 
examination  of  altered  retinoid  signaling  in  extra-hepatic  tissues  of  chronic  alcoholics  may  be  of 
interest for understanding the pathology of alcohol-induced diseases in addition to that of the liver. 
6. Summary 
Alcohol consumption has a profound effect on whole body retinoid homeostasis. This has been 
most carefully studied in the liver, where chronic alcohol consumption is associated with a depletion of 
hepatic retinyl ester and retinol levels. Though there is compelling data to support this observation in 
humans and rodent models, the mechanisms which underlie alcohol’s effect have not been definitively 
established; indeed, it appears that alcohol consumption has pleiotropic effects on hepatic retinoid 
metabolism. It is also important to emphasize that the effects of chronic alcohol consumption are tissue 
specific, such that alcohol is associated with a decrease in hepatic retinoid content, yet extra-hepatic 
retinoid levels are elevated. While future studies should yield an improved mechanistic understanding 
of the interactions between alcohol and retinoid metabolism, what will be most significant is definitive 
studies aimed at establishing if alcohol’s effect on hepatic retinoid homeostasis is directly linked with 
the  development  of  alcoholic  liver  disease.  The  growing  trend  towards  alcohol  feeding  studies  in 
genetically-engineered mutant mice should aid the discovery process, as well as the use of sensitive 
analytic methodologies for retinoid acid measurement. 
Acknowledgments 
This research was supported by the following grants from the National Institutes of Health: RC2 
AA019413, R01 DK68437, and R01 DK079221. 
Conflict of Interest 
The authors declare no conflict of interest. 
References 
1.  Best, C.A.; Laposata, M. Fatty acid ethyl esters: Toxic non-oxidative metabolites of ethanol and 
markers of ethanol intake. Front. Biosci. 2003, 8, e202–e217. 
2.  Isaksson, A.; Walther, L.; Hansson, T.; Andersson, A.; Alling, C. Phosphatidylethanol in blood 
(b-peth): A marker for alcohol use and abuse. Drug Test. Anal. 2011, 3, 195–200. 
3.  Shirakami,  Y.;  Lee,  S.A.;  Clugston,  R.D.;  Blaner,  W.S.  Hepatic  metabolism  of  retinoids  and 
disease associations. Biochim. Biophys. Acta 2012, 1821, 124–136. 
4.  Zachman,  R.D.;  Grummer,  M.A.  The  interaction  of  ethanol  and  vitamin  A  as  a  potential 
mechanism for the pathogenesis of fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 1998, 22, 
1544–1556. 
5.  Ballard, M.S.; Sun, M.; Ko, J. Vitamin A, folate, and choline as a possible preventive intervention 
to fetal alcohol syndrome. Med. Hypotheses 2012, 78, 489–493. 
6.  Lieber, C.S. Relationships between nutrition, alcohol use, and liver disease. Alcohol. Res. Health 
2003, 27, 220–231. 
7.  Halsted, C.H. Nutrition and alcoholic liver disease. Semin. Liver Dis. 2004, 24, 289–304. Nutrients 2012, 4  367 
 
 
8.  Patek, A.J.; Haig, C. The occurrence of abnormal dark adaptation and its relation to vitamin A 
metabolism in patients with cirrhosis of the liver. J. Clin. Invest. 1939, 18, 609–616. 
9.  Halsted, J.A.; Smith, J.C., Jr. Letter: Night blindness and chronic liver disease. Gastroenterology 
1974, 67, 193–194. 
10.  Majumdar, S.K.; Shaw, G.K.; Thomson, A.D. Vitamin A utilization status in chronic alcoholic 
patients. Int. J. Vitam. Nutr. Res. 1983, 53, 273–279. 
11.  Roncone, D.P. Xerophthalmia secondary to alcohol-induced malnutrition. Optometry 2006, 77, 
124–133. 
12.  Smith, J.C., Jr.; Brown, E.D.; White, S.C.; Finkelstein, J.D. Letter: Plasma vitamin A and zinc 
concentration in patients with alcoholic cirrhosis. Lancet 1975, 1, 1251–1252. 
13.  McClain, C.J.; van Thiel, D.H.; Parker, S.; Badzin, L.K.; Gilbert, H. Alterations in zinc, vitamin A, 
and retinol-binding protein in chronic alcoholics: A possible mechanism for night blindness and 
hypogonadism. Alcohol. Clin. Exp. Res. 1979, 3, 135–141. 
14.  Leo, M.A.; Lieber, C.S. Hepatic vitamin A depletion in alcoholic liver injury. New Engl. J. Med. 
1982, 307, 597–601. 
15.  Leo, M.A.; Sato, M.; Lieber, C.S. Effect of hepatic vitamin A depletion on the liver in humans 
and rats. Gastroenterology 1983, 84, 562–572. 
16.  Bell, H.; Nilsson, A.; Norum, K.R.; Pedersen, L.B.; Raknerud, N.; Rasmussen, M. Retinol and 
retinyl esters in patients with alcoholic liver disease. J. Hepatol. 1989, 8, 26–31. 
17.  Adachi, S.; Moriwaki, H.; Muto, Y.; Yamada, Y.; Fukutomi, Y.; Shimazaki, M.; Okuno, M.; 
Ninomiya, M. Reduced  retinoid content in hepatocellular carcinoma with special reference to 
alcohol consumption. Hepatology 1991, 14, 776–780. 
18.  Sato, M.; Lieber, C.S. Hepatic vitamin A depletion after chronic ethanol consumption in baboons 
and rats. J. Nutr. 1981, 111, 2015–2023. 
19.  Leo, M.A.; Kim, C.; Lieber, C.S. Increased vitamin A in esophagus and other extrahepatic tissues 
after chronic ethanol consumption in the rat. Alcohol. Clin. Exp. Res. 1986, 10, 487–492. 
20.  Mobarhan,  S.;  Layden,  T.J.;  Friedman,  H.;  Kunigk,  A.;  Donahue,  P.  Depletion  of  liver  and 
esophageal  epithelium vitamin A after chronic  moderate ethanol consumption in rats: Inverse 
relation to zinc nutriture. Hepatology 1986, 6, 615–621. 
21.  Mobarhan, S.; Seitz, H.K.; Russell, R.M.; Mehta, R.; Hupert, J.; Friedman, H.;  Layden, T.J.; 
Meydani, M.; Langenberg, P. Age-related effects of chronic ethanol intake on vitamin A status in 
fisher 344 rats. J. Nutr. 1991, 121, 510–517. 
22.  Chapman, K.; Prabhudesai, M.; Erdman, J.W., Jr. Effects of ethanol and carbon tetrachloride upon 
vitamin A status of rats. Alcohol. Clin. Exp. Res. 1992, 16, 764–768. 
23.  Wang, X.D.; Liu, C.; Chung, J.; Stickel, F.; Seitz, H.K.; Russell, R.M. Chronic alcohol intake 
reduces retinoic acid concentration and enhances ap-1 (c-jun and c-fos) expression in rat liver. 
Hepatology 1998, 28, 744–750. 
24.  Chung, J.; Liu, C.; Smith, D.E.; Seitz, H.K.; Russell, R.M.; Wang, X.D. Restoration of retinoic 
acid concentration suppresses ethanol-enhanced c-jun expression and hepatocyte proliferation in 
rat liver. Carcinogenesis 2001, 22, 1213–1219. 
25.  Liu, C.; Chung, J.; Seitz, H.K.; Russell, R.M.; Wang, X.D. Chlormethiazole treatment prevents 
reduced hepatic vitamin A levels in ethanol-fed rats. Alcohol. Clin. Exp. Res. 2002, 26, 1703–1709. Nutrients 2012, 4  368 
 
 
26.  Chung,  J.;  Veeramachaneni,  S.;  Liu,  C.;  Mernitz,  H.;  Russell,  R.M.;  Wang,  X.D.  Vitamin  E 
supplementation does not prevent ethanol-reduced hepatic retinoic acid levels in rats. Nutr. Res. 
2009, 29, 664–670. 
27.  Kane, M.A.; Folias, A.E.; Wang, C.; Napoli, J.L. Ethanol elevates physiological all-trans-retinoic 
acid  levels  in  select  loci  through  altering  retinoid  metabolism  in  multiple  loci:  A  potential 
mechanism of ethanol toxicity. FASEB J. 2010, 24, 823–832. 
28.  Luvizotto, R.A.; Nascimento, A.F.; Veeramachaneni, S.; Liu, C.; Wang, X.D. Chronic alcohol 
intake upregulates hepatic expression of carotenoid cleavage enzymes and ppar in rats. J. Nutr. 
2010, 140, 1808–1814. 
29.  Blaner,  W.S.;  O’Byrne,  S.M.;  Wongsiriroj,  N.;  Kluwe,  J.;  D’Ambrosio,  D.M.;  Jiang,  H.; 
Schwabe, R.F.; Hillman, E.M.; Piantedosi, R.; Libien, J. Hepatic stellate cell lipid droplets: A 
specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791, 467–473. 
30.  Rasmussen, M.; Blomhoff, R.; Helgerud, P.; Solberg, L.A.; Berg, T.; Norum, K.R. Retinol and 
retinyl  esters  in  parenchymal  and  nonparenchymal  rat  liver  cell  fractions  after  long-term 
administration of ethanol. J. Lipid Res. 1985, 26, 1112–1119. 
31.  Cottalasso, D.; Bassi, A.M.; Canepa, C.; Maloberti, G.; Casu, A.; Nanni, G. Chronic ethanol 
treatment: Dolichol and retinol distribution in isolated rat liver cells. Free Radic. Biol. Med. 2003, 
34, 337–344. 
32.  Leo, M.A.; Arai, M.; Sato, M.; Lieber, C.S. Hepatotoxicity of vitamin A and ethanol in the rat. 
Gastroenterology 1982, 82, 194–205. 
33.  Leo, M.A.; Lieber, C.S. Hepatic fibrosis after long-term administration of ethanol and moderate 
vitamin A supplementation in the rat. Hepatology 1983, 3, 1–11. 
34.  Seifert, W.F.; Bosma, A.; Hendriks, H.F.; Blaner, W.S.; van Leeuwen, R.E.; van Thiel-de Ruiter, 
G.C.;  Wilson,  J.H.;  Knook,  D.L.;  Brouwer,  A.  Chronic  administration  of  ethanol  with  high 
vitamin A supplementation in a liquid diet to rats does not cause liver fibrosis. 2. Biochemical 
observations. J. Hepatol. 1991, 13, 249–255. 
35.  Bosma,  A.;  Seifert,  W.F.;  Wilson,  J.H.;  Roholl,  P.J.;  Brouwer,  A.;  Knook,  D.L.  Chronic 
administration of ethanol with high vitamin A supplementation in a liquid diet to rats does not 
cause liver fibrosis. 1. Morphological observations. J. Hepatol. 1991, 13, 240–248. 
36.  Chung, J.; Chavez, P.R.; Russell, R.M.; Wang, X.D. Retinoic acid inhibits hepatic jun n-terminal 
kinase-dependent signaling pathway in ethanol-fed rats. Oncogene 2002, 21, 1539–1547. 
37.  Pan,  Z.;  Dan,  Z.;  Fu,  Y.;  Tang,  W.;  Lin,  J.  Low-dose  atra  supplementation  abolishes  PRM 
formation  in  rat  liver  and  ameliorates  ethanol-induced  liver  injury.  J.  Huazhong  Univ.  Sci. 
Technol. Med. Sci. 2006, 26, 508–512. 
38.  Leo, M.A.; Kim, C.; Lowe, N.; Lieber, C.S. Interaction of ethanol with beta-carotene: Delayed 
blood clearance and enhanced hepatotoxicity. Hepatology 1992, 15, 883–891. 
39.  Leo,  M.A.;  Aleynik,  S.I.;  Aleynik,  M.K.;  Lieber,  C.S.  Beta-carotene  beadlets  potentiate 
hepatotoxicity of alcohol. Am. J. Clin. Nutr. 1997, 66, 1461–1469. 
40.  Leo, M.A.; Kim, C.I.; Lieber, C.S. Increased vitamin A in esophagus and lungs after moderate 
ethanol consumption. Drug Nutr. Interact. 1988, 5, 227–236. 
41.  Sato, M.; Lieber, C.S. Changes in vitamin A status after acute ethanol administration in the rat.  
J. Nutr. 1982, 112, 1188–1196. Nutrients 2012, 4  369 
 
 
42.  Chapman, K.M.; Prabhudesai, M.; Erdman, J.W., Jr. Effects of acute ethanol doses or dietary 
phenobarbitol with carbon tetrachloride exposure on vitamin A status of rats. Alcohol. Clin. Exp. 
Res. 1993, 17, 637–642. 
43.  Balmer, J.E.; Blomhoff, R. Gene expression regulation by retinoic acid. J. Lipid Res. 2002, 43, 
1773–1808. 
44.  Napoli, J.L. Effects of ethanol on physiological retinoic acid levels. IUBMB Life 2011, 63, 701–706. 
45.  Sato, M.; Lieber, C.S. Increased metabolism of retinoic acid after chronic ethanol consumption in 
rat liver microsomes. Arch. Biochem. Biophys. 1982, 213, 557–564. 
46.  Molotkov, A.; Duester, G. Retinol/ethanol drug interaction during acute alcohol intoxication in 
mice involves inhibition of retinol metabolism to retinoic acid by alcohol dehydrogenase. J. Biol. 
Chem. 2002, 277, 22553–22557. 
47.  Sauvant, P.; Sapin, V.; Abergel, A.; Schmidt, C.K.; Blanchon, L.; Alexandre-Gouabau, M.C.; 
Rosenbaum, J.; Bommelaer, G.; Rock, E.; Dastugue, B.; et al. Pav-1, a new rat hepatic stellate 
cell line converts retinol into retinoic acid, a process altered by ethanol. Int. J. Biochem. Cell Biol. 
2002, 34, 1017–1029. 
48.  Wolf, G. Tissue-specific increases in endogenous all-trans retinoic acid: Possible contributing 
factor in ethanol toxicity. Nutr. Rev. 2010, 68, 689–692. 
49.  Leo, M.A.; Lieber, C.S. Alcohol, vitamin A, and beta-carotene: Adverse interactions, including 
hepatotoxicity and carcinogenicity. Am. J. Clin. Nutr. 1999, 69, 1071–1085. 
50.  Stryker, W.S.; Kaplan, L.A.; Stein, E.A.; Stampfer, M.J.; Sober, A.; Willett, W.C. The relation of 
diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol 
levels. Am. J. Epidemiol. 1988, 127, 283–296. 
51.  Ward,  R.J.;  Peters,  T.J.  The  antioxidant  status  of  patients  with  either  alcohol-induced  liver 
damage or myopathy. Alcohol Alcohol. 1992, 27, 359–365. 
52.  Ahmed, S.; Leo, M.A.; Lieber, C.S. Interactions between alcohol and beta-carotene in patients 
with alcoholic liver disease. Am. J. Clin. Nutr. 1994, 60, 430–436. 
53.  Forman,  M.R.;  Beecher,  G.R.;  Lanza,  E.;  Reichman,  M.E.;  Graubard,  B.I.;  Campbell,  W.S.;  
Marr, T.; Yong, L.C.; Judd, J.T.; Taylor, P.R. Effect of alcohol consumption on plasma carotenoid 
concentrations in premenopausal women: A controlled dietary study. Am. J. Clin. Nutr. 1995, 62, 
131–135. 
54.  Fukao, A.; Tsubono, Y.; Kawamura, M.; Ido, T.; Akazawa, N.; Tsuji, I.; Komatsu, S.; Minami, Y.; 
Hisamichi, S. The independent association of smoking and drinking with serum beta-carotene 
levels among males in miyagi, japan. Int. J. Epidemiol. 1996, 25, 300–306. 
55.  D’Ambrosio, D.N.; Clugston, R.D.; Blaner, W.S. Vitamin A metabolism: An update. Nutrients 
2011, 3, 63–103. 
56.  Friedman,  H.;  Mobarhan,  S.;  Hupert,  J.;  Lucchesi,  D.;  Henderson,  C.;  Langenberg,  P.;  
Layden, T.J. In vitro stimulation of rat liver retinyl ester hydrolase by ethanol. Arch. Biochem. 
Biophys. 1989, 269, 69–74. 
57.  Herr,  F.M.;  Ong,  D.E.  Differential  interaction  of  lecithin-retinol  acyltransferase  with  cellular 
retinol binding proteins. Biochemistry 1992, 31, 6748–6755. 
58.  Boerman,  M.H.;  Napoli,  J.L.  Cholate-independent  retinyl  ester  hydrolysis.  Stimulation  by  
apo-cellular retinol-binding protein. J. Biol. Chem. 1991, 266, 22273–22278. Nutrients 2012, 4  370 
 
 
59.  Kumar,  S.;  Sandell,  L.L.;  Trainor,  P.A.;  Koentgen,  F.;  Duester,  G.  Alcohol  and  aldehyde 
dehydrogenases: Retinoid metabolic effects in mouse knockout models. Biochim. Biophys. Acta 
2012, 1821, 198–205. 
60.  Napoli,  J.L.  Physiological  insights  into  all-trans-retinoic  acid  biosynthesis.  Biochim.  Biophys. 
Acta 2012, 1821, 152–167. 
61.  Han, C.L.; Liao, C.S.; Wu, C.W.; Hwong, C.L.; Lee, A.R.; Yin, S.J. Contribution to first-pass 
metabolism  of  ethanol  and  inhibition  by  ethanol  for  retinol  oxidation  in  human  alcohol 
dehydrogenase family—implications for etiology of fetal alcohol syndrome and alcohol-related 
diseases. Eur. J. Biochem. 1998, 254, 25–31. 
62.  Parlesak,  A.;  Menzl,  I.;  Feuchter,  A.;  Bode,  J.C.;  Bode,  C.  Inhibition  of  retinol  oxidation  by 
ethanol in the rat liver and colon. Gut 2000, 47, 825–831. 
63.  Kedishvili, N.Y.; Gough, W.H.; Davis, W.I.; Parsons, S.; Li, T.K.; Bosron, W.F. Effect of cellular 
retinol-binding protein on retinol oxidation by human class iv retinol/alcohol dehydrogenase and 
inhibition by ethanol. Biochem. Biophys. Res. Commun. 1998, 249, 191–196. 
64.  Ong, D.E.; Kakkad, B.; MacDonald, P.N. Acyl-coa-independent esterification of retinol bound to 
cellular retinol-binding protein (type II) by microsomes from rat small intestine. J. Biol. Chem. 
1987, 262, 2729–2736. 
65.  Leo, M.A.; Kim, C.I.; Lowe, N.; Lieber, C.S. Increased hepatic retinal dehydrogenase activity 
after phenobarbital and ethanol administration. Biochem. Pharmacol. 1989, 38, 97–103. 
66.  Ross, A.C.; Zolfaghari, R. Regulation of hepatic retinol metabolism: Perspectives from studies on 
vitamin A status. J. Nutr. 2004, 134, S269–S275. 
67.  Ross,  A.C.;  Zolfaghari,  R.  Cytochrome  p450s  in  the  regulation  of  cellular  retinoic  acid 
metabolism. Annu. Rev. Nutr. 2011, 31, 65–87. 
68.  Liu, C.; Russell, R.M.; Seitz, H.K.; Wang, X.D. Ethanol enhances retinoic acid metabolism into 
polar metabolites in rat liver via induction of cytochrome p4502e1. Gastroenterology 2001, 120, 
179–189. 
69.  Koop, D.R.; Tierney, D.J. Multiple mechanisms in the regulation of ethanol-inducible cytochrome 
p450IIE1. Bioessays 1990, 12, 429–435. 
70.  Wang, X.D. Alcohol, vitamin A, and cancer. Alcohol 2005, 35, 251–258. 
71.  Lee,  U.E.;  Friedman,  S.L.  Mechanisms  of  hepatic  fibrogenesis.  Best  Pract.  Res.  Clin. 
Gastroenterol. 2011, 25, 195–206. 
72.  Ryle, P.R.; Hodges, A.; Thomson, A.D. Inhibition of ethanol induced hepatic vitamin A depletion 
by administration of n,n′-diphenyl-p-phenylene-diamine (DPPD). Life Sci. 1986, 38, 695–702. 
73.  Takahashi, H.; Wong, K.; Jui, L.; Nanji, A.A.; Mendenhall, C.S.; French, S.W. Effect of dietary 
fat on ito cell activation by chronic ethanol intake: A long-term serial morphometric study on 
alcohol-fed and control rats. Alcohol. Clin. Exp. Res. 1991, 15, 1060–1066. 
74.  Dan, Z.; Popov, Y.; Patsenker, E.; Preimel, D.; Liu, C.; Wang, X.D.; Seitz, H.K.; Schuppan, D.; 
Stickel, F. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss 
of mitochondrial membrane potential. FASEB J. 2005, 19, 845–847. 
75.  Morimoto,  M.;  Reitz,  R.C.;  Morin,  R.J.;  Nguyen,  K.;  Ingelman-Sundberg,  M.;  French,  S.W.  
CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in 
rats by chronic administration of ethanol and a high fat diet. J. Nutr. 1995, 125, 2953–2964. Nutrients 2012, 4  371 
 
 
76.  Gouillon,  Z.;  Lucas,  D.;  Li,  J.;  Hagbjork,  A.L.;  French,  B.A.;  Fu,  P.;  Fang,  C.;  
Ingelman-Sundberg, M.; Donohue, T.M., Jr.; French, S.W. Inhibition of ethanol-induced liver 
disease in the intragastric feeding rat model by chlormethiazole. Proc. Soc. Exp. Biol. Med. 2000, 
224, 302–308. 
77.  Schutze,  M.;  Boeing,  H.;  Pischon,  T.;  Rehm,  J.;  Kehoe,  T.;  Gmel,  G.;  Olsen,  A.;  
Tjonneland, A.M.; Dahm, C.C.; Overvad, K.; et al. Alcohol attributable burden of incidence of 
cancer in eight european countries based on results from prospective cohort study. BMJ 2011, 
342, doi:10.1136/bmj.d1584. 
78.  Mak, K.M.; Leo, M.A.; Lieber, C.S. Ethanol potentiates squamous metaplasia of the rat trachea 
caused by vitamin A deficiency. Trans. Assoc. Am. Physicians 1984, 97, 210–221. 
79.  Mak, K.M.; Leo, M.A.; Lieber, C.S. Potentiation by ethanol consumption of tracheal squamous 
metaplasia caused by vitamin A deficiency in rats. J. Natl. Cancer Inst. 1987, 79, 1001–1010. 
80.  Mak, K.M.; Leo, M.A.; Lieber, C.S. Effect of ethanol and vitamin A deficiency on epithelial cell 
proliferation and structure in the rat esophagus. Gastroenterology 1987, 93, 362–370. 
81.  van Thiel, D.H.; Gavaler, J.; Lester, R. Ethanol inhibition of vitamin A metabolism in the testes: 
Possible mechanism for sterility in alcoholics. Science 1974, 186, 941–942. 
82.  Rosenblum,  E.R.;  Gavaler,  J.S.;  van  Thiel,  D.H.  Lipid  peroxidation:  A  mechanism  for  
alcohol-induced testicular injury. Free Radic. Biol. Med. 1989, 7, 569–577. 
©  2012  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 